You are here

Article info

Article menu

Download PDFPDF

Commentary
Immune checkpoint inhibitor-related acral vasculitis

Authors

  • Thibault Comont Service de Médecine Interne, Centre Hospitalier Universitaire Toulouse Purpan - Institut Universitaire du Cancer Toulouse Oncopole 1 av Joliot-Curie 31100 Toulouse France PubMed articlesGoogle scholar articles
  • Vincent Sibaud Service d’Oncodermatologie, Institut Universitaire du Cancer Toulouse Oncopole Toulouse France PubMed articlesGoogle scholar articles
  • Loïc Mourey Service d’Oncologie médicale, Institut Universitaire du Cancer Toulouse Oncopole Toulouse France PubMed articlesGoogle scholar articles
  • Pierre Cougoul Service de Médecine Interne, Centre Hospitalier Universitaire Toulouse Purpan - Institut Universitaire du Cancer Toulouse Oncopole 1 av Joliot-Curie 31100 Toulouse France PubMed articlesGoogle scholar articles
  • Odile Beyne-Rauzy Service de Médecine Interne, Centre Hospitalier Universitaire Toulouse Purpan - Institut Universitaire du Cancer Toulouse Oncopole 1 av Joliot-Curie 31100 Toulouse France PubMed articlesGoogle scholar articles
  1. ↵a +33 531 15 62 66 comont.thibault{at}iuct-oncopole.fr
  2. ↵b sibaud.vincent{at}iuct-oncopole.fr
  3. ↵c mourey.loic{at}iuct-oncopole.fr
  4. ↵d cougoul.pierre{at}iuct-oncopole.fr
  5. ↵e Beyne-rauzy.odile{at}iuct-oncopole.fr
View Full Text

Citation

Comont T, Sibaud V, Mourey L, et al
Immune checkpoint inhibitor-related acral vasculitis
Journal for ImmunoTherapy of Cancer 2018;6:120. doi: 10.1186/s40425-018-0443-6

Publication history

  • Received July 5, 2018
  • Accepted November 5, 2018
  • First published November 16, 2018.
Online issue publication 
February 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.